John Kaden
Managing Partner & CIO @ Navy Capital
New York, United States
John Kaden is a post-ipo equity investor at Navy Capital in New York focused on Cannabis and Biotechnology. John Kaden was co-Manager and Chief Investment Officer for Northwoods Capital Management Partners, a TMT-focused global long/short hedge fund. Prior to joining Northwoods, Mr. Kaden founded and managed Cynthion Partners from 2006 through the end of 2013, a global macro thematic hedge fund. Prior to founding Cynthion Partners, Mr. Kaden workedin the Strategic Division of Blackrock where he was instrumental in formulating and implementing the firm’s growth initiatives, including the transformative acquisition of State Street Research and the merger with Merrill Lynch Asset Management. Mr. Kaden began his career as a macro strategist for The G7 Group, a global consulting firm that advises its clients on macroeconomic and political developments that affect financial markets. Mr. Kaden graduated Magna Cum Laude with an A.B. from Harvard University and a J.D. from Yale Law School.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries John Kaden invests in
Stages John Kaden invests in
Countries John Kaden invests in
Investment Focus
Industry
- Cannabis 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
CLS focuses on the extraction and conversion of cannabinoids in the United States. The company extracts various cannabinoids from the marijuana plant and converts into concentrates, such as oils, waxes, edibles, and shatters. Its concentrates are used for electronic cigarettes vaporization, and pharmaceutical and other purposes. The company alsooffers consulting services to cannabis-related businesses comprising growers, dispensaries, and laboratories. | $3M / Post-IPO Equity / Aug 07, 2018 |
About Navy Capital
Navy Capital’s research-oriented, fundamentally-driven investment process focuses on identifying attractive opportunities within the legal cannabis space. Navy Capital seeks to find the best in class businesses within key verticals of the global cannabis industry. Those verticals include Consumer, Healthcare, Technology, Industrials, andAgriculture.
Navy Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Chetan Gulati
Partner and Head of Research
|
|||
|
John Kaden
Managing Partner & CIO
|
|||
|
Sean Stiefel
Founder and CEO
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does John Kaden invest in?
John Kaden invests primarily in Cannabis and Biotechnology startups, most often at Post-IPO Equity stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did John Kaden last invest?
The most recent investment recorded for John Kaden closed in Aug 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!